103 related articles for article (PubMed ID: 25988615)
1. A new pregnenolone analogues as privileged scaffolds in inhibition of CYP17 hydroxylase enzyme. Synthesis and in silico molecular docking study.
Al-Masoudi NA; Mahdi KM; Abdul-Rida NA; Saeed BA; Engel M
Steroids; 2015 Aug; 100():52-9. PubMed ID: 25988615
[TBL] [Abstract][Full Text] [Related]
2. New CYP17 hydroxylase inhibitors: synthesis, biological evaluation, QSAR, and molecular docking study of new pregnenolone analogs.
Al-Masoudi NA; Ali DS; Saeed B; Hartmann RW; Engel M; Rashid S; Saeed A
Arch Pharm (Weinheim); 2014 Dec; 347(12):896-907. PubMed ID: 25251696
[TBL] [Abstract][Full Text] [Related]
3. New biaryl-chalcone derivatives of pregnenolone via Suzuki-Miyaura cross-coupling reaction. Synthesis, CYP17 hydroxylase inhibition activity, QSAR, and molecular docking study.
Al-Masoudi NA; Kadhim RA; Abdul-Rida NA; Saeed BA; Engel M
Steroids; 2015 Sep; 101():43-50. PubMed ID: 26051784
[TBL] [Abstract][Full Text] [Related]
4. Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls.
Hille UE; Hu Q; Vock C; Negri M; Bartels M; Müller-Vieira U; Lauterbach T; Hartmann RW
Eur J Med Chem; 2009 Jul; 44(7):2765-75. PubMed ID: 19211174
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, 17α-hydroxylase-C
Banday AH; Shameem SA; Banday JA; Ganaie BA
Anticancer Agents Med Chem; 2018; 18(13):1919-1926. PubMed ID: 29697032
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2.
Hartmann RW; Hector M; Haidar S; Ehmer PB; Reichert W; Jose J
J Med Chem; 2000 Nov; 43(22):4266-77. PubMed ID: 11063622
[TBL] [Abstract][Full Text] [Related]
7. Modeling androgen receptor flexibility: a binding mode hypothesis of CYP17 inhibitors/antiandrogens for prostate cancer therapy.
Gianti E; Zauhar RJ
J Chem Inf Model; 2012 Oct; 52(10):2670-83. PubMed ID: 22924551
[TBL] [Abstract][Full Text] [Related]
8. Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy.
Clement OO; Freeman CM; Hartmann RW; Handratta VD; Vasaitis TS; Brodie AM; Njar VC
J Med Chem; 2003 Jun; 46(12):2345-51. PubMed ID: 12773039
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation.
Lin CJ; Cheng LC; Lin TC; Wang CJ; Li LA
Biochem Pharmacol; 2014 Aug; 90(3):288-96. PubMed ID: 24875446
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17).
Hartmann RW; Hector M; Wachall BG; Palusczak A; Palzer M; Huch V; Veith M
J Med Chem; 2000 Nov; 43(23):4437-45. PubMed ID: 11087568
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure.
Jagusch C; Negri M; Hille UE; Hu Q; Bartels M; Jahn-Hoffmann K; Pinto-Bazurco Mendieta MA; Rodenwaldt B; Müller-Vieira U; Schmidt D; Lauterbach T; Recanatini M; Cavalli A; Hartmann RW
Bioorg Med Chem; 2008 Feb; 16(4):1992-2010. PubMed ID: 18061460
[TBL] [Abstract][Full Text] [Related]
12. Novel oxazolinyl derivatives of pregna-5,17(20)-diene as 17α-hydroxylase/17,20-lyase (CYP17A1) inhibitors.
Kuzikov AV; Dugin NO; Stulov SV; Shcherbinin DS; Zharkova MS; Tkachev YV; Timofeev VP; Veselovsky AV; Shumyantseva VV; Misharin AY
Steroids; 2014 Oct; 88():66-71. PubMed ID: 24971814
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17)--part II: Core rigidification and influence of substituents at the methylene bridge.
Hu Q; Negri M; Jahn-Hoffmann K; Zhuang Y; Olgen S; Bartels M; Müller-Vieira U; Lauterbach T; Hartmann RW
Bioorg Med Chem; 2008 Aug; 16(16):7715-27. PubMed ID: 18674917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer.
Pinto-Bazurco Mendieta MA; Negri M; Jagusch C; Müller-Vieira U; Lauterbach T; Hartmann RW
J Med Chem; 2008 Aug; 51(16):5009-18. PubMed ID: 18672868
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid residue, Ala 105, confers 16alpha-hydroxylase activity to human cytochrome P450 17alpha-hydroxylase/17,20 lyase.
Swart AC; Storbeck KH; Swart P
J Steroid Biochem Mol Biol; 2010 Apr; 119(3-5):112-20. PubMed ID: 20043997
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and evaluation of N-alkynylaminosteroids as potential CYP450 17A1 inhibitors].
Panada JU; Faletrov YV; Frolova NS; Shkumatov VM
Biomed Khim; 2019 Jun; 65(4):324-330. PubMed ID: 31436174
[TBL] [Abstract][Full Text] [Related]
17. Computational prediction of new CYP17 inhibitors based on pharmacophore modeling, virtual screening and docking approach.
Haidar S; Hartmann RW
Pharmazie; 2017 Sep; 72(9):529-536. PubMed ID: 29441980
[TBL] [Abstract][Full Text] [Related]
18. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
19. In vitro effects of brominated flame retardants and metabolites on CYP17 catalytic activity: a novel mechanism of action?
Cantón RF; Sanderson JT; Nijmeijer S; Bergman A; Letcher RJ; van den Berg M
Toxicol Appl Pharmacol; 2006 Oct; 216(2):274-81. PubMed ID: 16828825
[TBL] [Abstract][Full Text] [Related]
20. Variation in 3β-hydroxysteroid dehydrogenase activity and in pregnenolone supply rate can paradoxically alter androstenedione synthesis.
Nguyen PT; Lee RS; Conley AJ; Sneyd J; Soboleva TK
J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):12-20. PubMed ID: 22024430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
